Navigation Links
BioRestorative Therapies Signs License Agreement With University of Utah to Obtain Adipose (Fat) Tissue for its ThermoStem Program to Treat Obesity and Metabolic Disorders
Date:8/25/2011

JUPITER, Fla., Aug. 25, 2011 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: SCLZ) ("BRT") today announced that it has entered into a Tangible Property License Agreement with the University of Utah.  The two year license agreement enables BioRestorative Therapies to obtain adipose (fat) tissue that will be used for research purposes to develop and commercialize its ThermoStem Program, which is an adult derived stem cell-based program to treat metabolic and obesity related disorders, using the thermogenic or heat producing properties of brown fat.  

The agreement marks the beginning of a strategic collaboration between BRT and the University of Utah, an institution recognized as a leader in translational stem cell-based therapies.  This relationship offers BRT an opportunity to procure adipose tissues from donors (tissue and cells that are usually difficult to obtain) to be used for BRT's cellular research and characterization studies.

Dr. Amit Patel, Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah and a member of the BRT Scientific Advisory Board, said, "Obesity is now the leading cause of preventable death and BRT's ThermoStem Program is a novel cell-based approach to treat this disorder."

Mark Weinreb, Chairman and CEO of BioRestorative Therapies, said, "We have been developing our ThermoStem Program to treat metabolic and obesity related disorders and the signing of this agreement with the University of Utah brings us closer to realizing clinical applications."

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.'s goal is to become a medical center of excellence using cell and tissue protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. In June 2011, the Company launched a platform technology that involves the use of
'/>"/>

SOURCE BioRestorative Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cardium Announces Receipt of $1.1 Million in Funds from Philips Acquisition of Innercool Therapies
2. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
3. B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System
4. MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment
5. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
6. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
7. Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows Promising Results in Patients with Most Common Mutation
8. Approved Biologic Therapies in Rheumatoid Arthritis Show Further Evidence of Efficacy and Reduction in Joint Damage at the 2011 European League Against Rheumatisms Congress
9. Restorative Therapies, Inc., Today Announced a Rehabilitation Breakthrough, the RT600 Functional Electrical Stimulation (FES) Stepper
10. Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
11. PNP Therapeutics Meets Important Financial and Regulatory Objectives in Development of New Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
(Date:3/27/2015)... March 27, 2015 According to ... (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, ... Indication (AF, VT, WPW) - Global Forecasts to 2019 ", ... to reach around ~$4.73 Billion by 2019 with a ... to 2019. Browse   90   ...
(Date:3/27/2015)... Mass. , March 27, 2015 /PRNewswire/ ... and privately-held MirImmune LLC, today announced that ... agreement to RXi,s novel and proprietary sd-rxRNA® ... cancer immunotherapies. The collaboration has the potential ... patient friendly cancer treatments that could be ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
(Date:3/29/2015)... Final Cut Pro X plugin ... Studios, entitled TranSports. , “TranSports is a compilation ... Pro X,” said Christiana Austin, CEO of Pixel Film ... effortlessly transition using this cool sports transition tool.” , ... styled transition pack for Final Cut Pro X. TranSports ...
(Date:3/28/2015)... March 28, 2015 Could genetic code ... new study by researchers at the Harvard ... with the support of the Coffee and Caffeine Genetics ... Psychiatry this past fall, the study—one of several recent ... genomic data from more than 120,000 regular coffee drinkers ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs has prepared a ... during the Easter Holidays from today until April 6th. ... Fools’ Day. , As the winter fades and spring ... Festival, with religious origins to countries in Europe and ... The best wig provider, UniWigs, would like to offer ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Pitching speed, ... a history of shoulder and elbow injuries, according to new ... Medicine’s ( AOSSM ) Specialty Day. , “Our findings indicate ... a 20% increase in likelihood of a history of injury, ... with a 12% increase likelihood of a history of injury, ...
(Date:3/28/2015)... Raleigh, NC (PRWEB) March 28, 2015 ... people with peritoneal mesothelioma, revealing, for the first time, ... Click here to read the newly posted story ... scientists at the University of British Columbia, the British ... used genome mapping to reveal underlying molecular alterations and ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2
... The increase in the number of U.S. medical students ... sign toward easing the primary care workforce shortage, according ... second-largest doctors group. The 2011 National Resident Matching ... from last year, with 2,940 U.S. seniors at medical ...
... Arbor, Mich. Providing kidney transplants to patients with ... transplant operations and improve life span after kidney transplant, ... the New England Journal of Medicine March 16., Alan ... and his co-authors endorsed new concepts designed to improve ...
... N.J. (March 16, 2011) The Multiple Myeloma Research ... Hackensack University Medical Center, member of the Multiple Myeloma ... in Multiple Myeloma Patient Symposium on Saturday, April 2 ... program is for patients and caregivers who want to ...
... released new official clinical guidelines on the diagnosis ... statement replaces ATS guidelines published in 2000, and ... and management of IPF, as well as available ... palliative care. , The statement appears in the ...
... By Maureen Salamon HealthDay Reporter , ... on Parkinson,s disease patients significantly improved the tremors, rigidity ... the illness, a small new study reports. The ... advanced Parkinson,s disease, with half randomly assigned to receive ...
... shows that it is feasible to screen for undiagnosed ... arrest (SCA). Adding a 10-minute electrocardiogram (EKG or ECG) ... of potentially serious heart conditions. Although more ... relatively low-cost screening might help identify children who are ...
Cached Medicine News:Health News:Residency match results encouraging for adults needing primary care 2Health News:Survival matching should be used to allocate donated kidneys to transplant recipients 2Health News:Survival matching should be used to allocate donated kidneys to transplant recipients 3Health News:The MMRF and John Theurer Cancer Center to host patient symposium 2Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 2Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 3Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 4Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:In pilot study, screening detects potentially serious heart conditions in healthy children 2
5mm from bend to tip 0.3x2.0mm Tip, Oblong 2 Sided Straight, at 45 degrees; In Titanium...
Angled 40 Degrees, 0.6x0.8 Elliptical Tip; in Titanium...
Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Medicine Products: